Discovery of serum biomarkers for pancreatic adenocarcinoma using proteomic analysis
Open Access
- 29 June 2010
- journal article
- research article
- Published by Springer Science and Business Media LLC in British Journal of Cancer
- Vol. 103 (3), 391-400
- https://doi.org/10.1038/sj.bjc.6605764
Abstract
Background and aims: Methods: Results: Conclusions:Keywords
This publication has 40 references indexed in Scilit:
- Identification of serum biomarkers for pancreatic adenocarcinoma by proteomic analysisCancer Science, 2009
- Effect of weight loss on HDL-apoA-II kinetics in the metabolic syndromeClinical Science, 2009
- Differential Stability of High-density Lipoprotein Subclasses: Effects of Particle Size and Protein CompositionJournal of Molecular Biology, 2009
- Postresection CA 19-9 Predicts Overall Survival in Patients With Pancreatic Cancer Treated With Adjuvant Chemoradiation: A Prospective Validation by RTOG 9704Journal of Clinical Oncology, 2008
- Improved Diagnosis of Pancreatic Adenocarcinoma Using Haptoglobin and Serum Amyloid A in a Panel ScreenWorld Journal of Surgery, 2008
- Smoking and serum CA19‐9 levels according to Lewis and secretor genotypesInternational Journal of Cancer, 2008
- Biomarker Identification in Human Pancreatic Cancer SeraPancreas, 2008
- Systematic review of carbohydrate antigen (CA 19-9) as a biochemical marker in the diagnosis of pancreatic cancerEuropean Journal of Surgical Oncology, 2007
- Plasma Factors Required for Human Apolipoprotein A-II DimerizationBiochemistry, 2004
- Effects of interactions of apolipoprotein A-II with apolipoproteins A-I or A-IV on [3H]cholesterol efflux and uptake in cell cultureBiochimica et Biophysica Acta (BBA) - Lipids and Lipid Metabolism, 1995